FDA Repays Industry by Rushing Risky Drugs to Market — As pharma companies underwrite 3/4 of the FDA’s budget for scientific reviews, the agency is increasingly fast-tracking expensive drugs with significant side effects & unproven health benefits.

FDA Repays Industry by Rushing Risky Drugs to Market — As pharma companies underwrite 3/4 of the FDA’s budget for scientific reviews, the agency is increasingly fast-tracking expensive drugs with significant side effects & unproven health benefits.: https://ift.tt/2lDuEjP Read more... https://ift.tt/2MshVw3